Biocon, SII join hands to focus on vaccines, other biotech products
BBL to offload 15% stake to SILS; to get 100 million doses annually for 15 years17-09-2021
17-09-2021
Bharat Bijlee Ltd - 503960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
NEWSPAPER NOTICE FOR THE 74TH ANNUAL GENERAL MEETING, REMOTE E-VOTING INFORMATION AND BOOK CLOSURE DATES07-09-2021
BHARAT BIJLEE LTD.-$ - 503960 - Shareholder Meeting - AGM On Friday, September 24, 2021, Through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM')
NOTICE OF THE 74TH ANNUAL GENERAL MEETING ('AGM') OF THE COMPANY & CUT-OFF DATE FOR THE PURPOSE OF AGM03-09-2021
BHARAT BIJLEE LTD.-$ - 503960 - Reg. 34 (1) Annual Report
SUBMISSION OF ANNUAL REPORT FOR THE FINANCIAL YEAR 2020-202101-09-2021
Bharat Bijlee Ltd - 503960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Compliance under Regulation 47 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Financial Results Newspaper Publication06-08-2021
Bharat Bijlee Ltd - 503960 - Fixes Book Closure for Dividend & AGM
Bharat Bijlee Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 17, 2021 to September 24, 2021 (both days inclusive) for the purpose of Payment of Dividend & 74th Annual General Meeting (AGM) of the Company to be held on September 24, 2021.05-08-2021
Bharat Bijlee Ltd - 503960 - Results-Financial Results For The Quarter Ended June 30, 2021
Statement of Unaudited Financial Results for the Quarter Ended June 30, 202104-08-2021
BHARAT BIJLEE LTD.-$ - 503960 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board Meeting held on Wednesday, August 04, 202104-08-2021
Bharat Bijlee Ltd - 503960 - Board Meeting Intimation for The Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2021
BHARAT BIJLEE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2021 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter ended June 30, 202123-07-2021